Trials / Completed
CompletedNCT03824366
Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy
Pilot Study of Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy (MAP-RT)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This proposed study is unique in that patients will not undergo computed tomography (CT) simulation at any point during their treatment course and will instead have same-session magnetic resonance (MR)-only simulation and treatment planning, on-table, using the adaptive radiotherapy (ART) workflow. In this manner, patients requiring urgent treatment could initiate treatment as early as the day of initial radiation oncology consultation.
Conditions
- Malignancy
- Metastasis
- Hemoptysis
- Gastrointestinal Bleeding
- Pelvic Bleeding
- Superior Vena Cava Syndrome
- Mediastinal Disease
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Volumetric MR imaging | This will most frequently be supine with arms positioned so not in the way of treatment beams. |
| RADIATION | Radiation therapy | -Standard of care |
Timeline
- Start date
- 2019-04-23
- Primary completion
- 2022-01-14
- Completion
- 2022-01-14
- First posted
- 2019-01-31
- Last updated
- 2025-01-10
- Results posted
- 2023-01-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03824366. Inclusion in this directory is not an endorsement.